Grant: Discovery Grants Program - Individual
University of Guelph
$40,000.00
Pathogenesis of enzootic nasal tumor virus (ENTV)
EF 2008-09
Résumé
Animal models of retrovirus-induced tumors have provided us with much of the foundation for our current understanding of the oncogenic process. Two economically important retroviruses associated with tumors of secretory respiratory epithelial cells are the Jaagsiekte sheep retrovirus (JSRV) and Enzootic nasal tumor virus (ENTV) of sheep and goats. While JSRV and ENTV are highly related betaretroviruses that utilize the same cell surface receptor for virus entry, they have distinct tumor-inducing capabilities. JSRV transforms alveolar type II pneumocytes, while ENTV transforms nasal epithelial cells. The reason for this is not known. This proposal addresses the hypothesis that induction of tissue-specific tumor formation in the ovine host is either a function of cell-restricted activity of the long terminal repeat (LTR) or due to the fact that ENTV and JSRV require a coreceptor for virus entry and differences in affinity or coreceptor usage determines cellular tropism. To address these hypotheses, a molecular clone of ENTV will be constructed and used to generate infectious virus for in vivo studies. Upon demonstration that ENTV is the etiologic agent of enzootic nasal adenocarcinoma, a series of chimeric viruses generated via the exchange of genetic material between JSRV and ENTV will be constructed and used to map genetic elements responsible for tissue-specific tumor formation. Specifically, the potential for coreceptor usage and restricted LTR activity will be addressed in these experiments. It is anticipated that this research program will contribute to our understanding of virally-induced cancers, uncover a potentially novel mechanism for retrovirus entry, and shed light on the mechanisms governing neoplastic transformation of secretory respiratory epithelial cells. Currently, no antemortem diagnostic tools are available for ENTV. Therefore, creating an animal model for ENTV infection allows for analysis of the cellular and tissue distribution of ENTV and subsequent identification of sensitive template sources for ENTV nucleic acid amplification. PCR-based diagnostic assays could then be developed and implemented in test and removal programs aimed at eradicating ENTV from Canadian sheep and goat flocks.
Programme
Discovery Grants Program - Individual
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data
Tel que publié
Application id
355661-2008
Name nom
Wootton, Sarah
Department département
Pathobiology
Organization id
24
Institution établissement
University of Guelph
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2008
Competition year année de concours
2008
Award amount
40000
Program id
RGPIN
Program nane en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
32
Committee name en
Cell Biology
Committee name fr
Biologie cellulaire
Area of application code
1200
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Advancement of knowledge
Area of application fr
Avancement des connaissances
Research subject code
5202
Research subject group en
Microbiology
Research subject group fr
Microbiologie
Research subject en
Virology
Research subject fr
Virologie
Partie
1
Nb partie
5
Application title
Pathogenesis of enzootic nasal tumor virus (ENTV)
Keyword
NA
Application summary
Animal models of retrovirus-induced tumors have provided us with much of the foundation for our current understanding of the oncogenic process. Two economically important retroviruses associated with tumors of secretory respiratory epithelial cells are the Jaagsiekte sheep retrovirus (JSRV) and Enzootic nasal tumor virus (ENTV) of sheep and goats. While JSRV and ENTV are highly related betaretroviruses that utilize the same cell surface receptor for virus entry, they have distinct tumor-inducing capabilities. JSRV transforms alveolar type II pneumocytes, while ENTV transforms nasal epithelial cells. The reason for this is not known. This proposal addresses the hypothesis that induction of tissue-specific tumor formation in the ovine host is either a function of cell-restricted activity of the long terminal repeat (LTR) or due to the fact that ENTV and JSRV require a coreceptor for virus entry and differences in affinity or coreceptor usage determines cellular tropism. To address these hypotheses, a molecular clone of ENTV will be constructed and used to generate infectious virus for in vivo studies. Upon demonstration that ENTV is the etiologic agent of enzootic nasal adenocarcinoma, a series of chimeric viruses generated via the exchange of genetic material between JSRV and ENTV will be constructed and used to map genetic elements responsible for tissue-specific tumor formation. Specifically, the potential for coreceptor usage and restricted LTR activity will be addressed in these experiments. It is anticipated that this research program will contribute to our understanding of virally-induced cancers, uncover a potentially novel mechanism for retrovirus entry, and shed light on the mechanisms governing neoplastic transformation of secretory respiratory epithelial cells. Currently, no antemortem diagnostic tools are available for ENTV. Therefore, creating an animal model for ENTV infection allows for analysis of the cellular and tissue distribution of ENTV and subsequent identification of sensitive template sources for ENTV nucleic acid amplification. PCR-based diagnostic assays could then be developed and implemented in test and removal programs aimed at eradicating ENTV from Canadian sheep and goat flocks.